<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Only two (2.5%) of 80 outpatients with histologically proven <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> had <z:chebi fb="3" ids="37445">folate</z:chebi> deficiency associated with <z:hpo ids='HP_0001903'>anaemia</z:hpo> or <z:mp ids='MP_0000248'>macrocytosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Mean <z:chebi fb="3" ids="37445">folate</z:chebi> absorption, measured using micrograms/kg body weight of a <z:chebi fb="13" ids="29298">tritium</z:chebi>-labelled physiological <z:chebi fb="3" ids="37445">folate</z:chebi> derivative, 5-methyltetrahydroteroylglutamic acid, in six newly diagnosed patients was 76.7% (<z:mpath ids='MPATH_458'>normal</z:mpath> greater than 95%) but fell to 69.4% after three months' treatment with sulphasalazine </plain></SENT>
<SENT sid="2" pm="."><plain>Mean difference in individual patients was 7.5% +/- 5.2% (SD) (p less than 0.02) </plain></SENT>
<SENT sid="3" pm="."><plain>Mean <z:chebi fb="3" ids="37445">folate</z:chebi> absorption in four patients with <z:e sem="disease" ids="C0002888" disease_type="Disease or Syndrome" abbrv="">megaloblastic</z:e> <z:hpo ids='HP_0001903'>anaemia</z:hpo> or <z:mp ids='MP_0000248'>macrocytosis</z:mp> which developed during treatment with sulphasalazine was 66.3% </plain></SENT>
<SENT sid="4" pm="."><plain>This rose to 82.4% after the drug was stopped </plain></SENT>
<SENT sid="5" pm="."><plain>Mean difference in individual patients was 16.6 +/- 6.6% (SD) (p less than 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients who developed <z:hpo ids='HP_0001903'>anaemia</z:hpo> or <z:mp ids='MP_0000248'>macrocytosis</z:mp> with sulphasalazine had additional reasons for <z:chebi fb="3" ids="37445">folate</z:chebi> deficiency </plain></SENT>
<SENT sid="7" pm="."><plain>These included <z:e sem="disease" ids="C0007570" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">coeliac disease</z:e>, severe <z:e sem="disease" ids="C0267975" disease_type="Disease or Syndrome" abbrv="">nutritional deficiencies</z:e>, and haemolysis </plain></SENT>
<SENT sid="8" pm="."><plain>It was concluded that sulphasalazine impairs <z:chebi fb="3" ids="37445">folate</z:chebi> absorption but this only becomes significant if other reasons for <z:chebi fb="3" ids="37445">folate</z:chebi> deficiency are also present </plain></SENT>
</text></document>